Corcept Therapeutics
CORT
CORT
365 hedge funds and large institutions have $4.24B invested in Corcept Therapeutics in 2024 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 116 increasing their positions, 121 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.01% less ownership
Funds ownership: 83.4% → 80.38% (-3%)
21% less call options, than puts
Call options by funds: $58.4M | Put options by funds: $73.7M
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
365
Holding in Top 10
5
Calls
$58.4M
Puts
$73.7M
Top Buyers
| 1 | +$17.8M | |
| 2 | +$14.9M | |
| 3 | +$13.6M | |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
+$12.7M |
| 5 |
Goldman Sachs
New York
|
+$7.72M |
Top Sellers
| 1 | -$112M | |
| 2 | -$31M | |
| 3 | -$22.9M | |
| 4 |
BlackRock
New York
|
-$18.8M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$15.7M |